Running on Empty: ME/CFS Patients Are Missing Up to 15% of Their Blood
The average adult has about 5 liters of blood. Now imagine waking up every morning with 500 to 750 ml less — permanently. No injury, no bleeding, no obvious cause. Just… less blood.
That’s the reality for many people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). And it may be one of the most straightforward explanations for why they’re exhausted.
1 How large are the deficits?
Blood volume deficits in ME/CFS are not subtle. They’ve been measured with gold-standard techniques — radiolabeled red blood cells and dual-isotope dilution — across multiple independent studies:
- Total blood volume: 10-15% below predicted values (Newton et al. 2016) (Streeten and Bell 1998)
- Plasma volume (the liquid portion): 21% lower in POTS patients — a condition overlapping with ME/CFS in ~60% of cases (Raj et al. 2005); 11 ml/kg below reference in ME/CFS patients (Campen, Rowe, and Visser 2018)
- Red blood cell mass: reduced in 94% of female and 50% of male ME/CFS patients (Streeten and Bell 1998)
To put this in perspective: a blood donation takes about 10% of your blood volume. These patients are living, permanently, in a state comparable to having just donated blood — except their body never replenishes the deficit.
2 Blood volume, cardiac output, and the energy chain
The connection between blood volume and energy is not complicated:
Less blood volume means less blood returning to the heart (reduced venous return). Less venous return means the heart fills less with each beat (reduced preload). Less preload means each heartbeat pumps less blood (reduced stroke volume). Less blood pumped means less oxygen reaching tissues. Less oxygen means less ATP — the molecular fuel that powers everything you do.
Cardiac MRI studies confirm this chain directly: ME/CFS patients have reduced left ventricular end-diastolic volume (the heart fills less) and reduced stroke volume (each beat pumps less), with strong correlations to measured blood volume (Newton et al. 2016). Crucially, these reductions are disproportionate to inactivity level — this is not deconditioning. The same study found no relationship between disease duration and cardiac volumes, ruling out gradual physical decline as the explanation.
The brain sits at the end of this chain and has nowhere to borrow from. Cerebral blood flow can be reduced by up to 40% in ME/CFS, driven by low cardiac output, autonomic dysfunction, reduced blood volume, and impaired autoregulation acting together. Unlike other organs, the brain cannot meaningfully compensate — which is why patients report cognitive dysfunction (“brain fog”) and difficulty concentrating, and why many feel noticeably sharper lying down, where improved venous return restores cerebral perfusion.
3 A hormonal system that fails to respond
Here’s where it gets strange. Your body has a well-tested system for detecting low blood volume and correcting it: the renin-angiotensin-aldosterone system (RAAS). When blood volume drops, the kidneys release renin, which triggers a cascade ending in aldosterone — a hormone that tells the kidneys to retain sodium and water, expanding blood volume.
In ME/CFS, this system is paradoxically suppressed.
Miwa & Fujita (Miwa and Fujita 2017) found that ME/CFS patients had 33% lower aldosterone and 33% lower antidiuretic hormone (ADH) than healthy controls — despite documented hypovolemia. The hormonal response was to retain less fluid, not more.
Raj et al. (Raj et al. 2005) found the same paradox in POTS patients (a condition overlapping with ME/CFS in about 60% of cases): blood volume was markedly reduced, but plasma renin activity was unchanged and aldosterone was low. The volume-sensing system was broken.
The result is a self-perpetuating deficit. The body is low on blood, but the hormonal systems that should correct this are either suppressed or unresponsive. Why this happens — whether it’s central nervous system dysregulation, autoimmune interference with hormone receptors, or something else — remains an open research question.
4 Reduced quantity, compromised quality
Even the blood that remains doesn’t work optimally. Red blood cells in ME/CFS patients show reduced deformability (Saha et al. 2019) — they’re stiffer and less able to squeeze through capillaries to deliver oxygen. This means that even if you could magically restore blood volume overnight, oxygen delivery would still be impaired at the tissue level.
On top of that, inflammatory cytokines (IL-6, TNF-alpha) — which are elevated in ME/CFS — suppress the production of new red blood cells (erythropoiesis) and sequester iron, creating a pattern resembling anemia of chronic disease. The blood is not just reduced in quantity; its quality is compromised.
5 Standing up on a 15% deficit
Low blood volume hits hardest the moment a patient stands up. When you rise from lying to upright, gravity pulls about 500-700 ml of blood into your legs and abdomen; a healthy person compensates by constricting blood vessels and accelerating heart rate. Someone who is already 500-750 ml short starts that compensatory effort in a hole they cannot climb out of.
This is why 70-90% of ME/CFS patients experience orthostatic intolerance — and it is not anxiety or deconditioning. It is physics: there literally is not enough blood to maintain adequate brain perfusion while standing.
The flip side is equally telling: many patients feel noticeably better lying down. Horizontal position eliminates the gravitational drain, allowing the limited blood volume to distribute evenly and reach the brain. When a patient says they can only think clearly while lying flat, that’s not a psychological preference — it’s their cardiovascular system working within its constraints.
6 Managing the deficit — and looking for the cause
Several approaches address the deficit directly, with varying mechanisms:
- Salt and fluid loading (8-10 g sodium/day, 2-3 L fluids): Expands plasma volume. In someone with normal blood volume, this would raise blood pressure harmfully. In hypovolemic ME/CFS patients, it partially corrects a deficit.
- Fludrocortisone: A mineralocorticoid that does what the patient’s own aldosterone fails to do — tells the kidneys to retain sodium and water. Takes 1-2 weeks for full effect.
- Compression garments: Mechanical counterpressure that reduces venous pooling in the legs and abdomen, keeping more blood in central circulation.
- Desmopressin: An ADH analog that replaces the missing antidiuretic hormone. Improved orthostatic symptoms in 50% of patients in Miwa’s trial.
These interventions help — but they’re managing the deficit, not fixing the cause. So why are the volume-regulatory hormones suppressed?
One leading theory points to autoantibodies — immune proteins that mistakenly target the body’s own receptors. ME/CFS patients show elevated autoantibodies against G protein-coupled receptors (GPCRs), including angiotensin II AT1 receptors (Loebel et al. 2016) (Freitag et al. 2021) (Bynke et al. 2020). The AT1 receptor is a key link in the RAAS chain: angiotensin II binds it to trigger aldosterone release. Autoantibodies interfering with this receptor would directly explain why the system fails to correct low blood volume — the signal gets through, but the receptor doesn’t respond normally.
This is still a hypothesis, not established fact. But it’s testable: three complementary approaches — immunoadsorption (filtering autoantibodies from blood), BC007 (a synthetic molecule that neutralizes them), and daratumumab (targeting the cells that produce them) — are in active clinical trials. If the autoantibody theory is correct, these treatments could fix the RAAS suppression at its source — restoring the body’s ability to regulate its own blood volume.
7 A measurable deficit that rarely gets measured
Blood volume is not a questionnaire score or a self-reported symptom. It is milliliters of fluid measured with radioisotopes, and the deficits documented here are large enough to explain a significant portion of the disability.
Yet blood volume testing is rarely performed in clinical practice. Most ME/CFS patients have never had their blood volume measured. Standard blood tests (complete blood count, hemoglobin) can appear completely normal even with a 15% blood volume deficit — because the concentration of red blood cells is preserved even as the total volume drops.
This is arguably one of the most actionable findings in ME/CFS research: a measurable deficit with available treatments. The barrier isn’t knowledge — it’s implementation.
8 Caveats and scope
Not all ME/CFS patients show the same degree of hypovolemia. Blood volume reduction may represent a subtype or a contributing factor rather than a universal mechanism. The numbers cited here come from studies with sample sizes of 14-42 patients — significant for ME/CFS research, but not large by general medical standards. And the relationship between blood volume and overall ME/CFS severity, while correlated, is not the complete picture — immune dysfunction, mitochondrial impairment, and neurological factors all contribute independently.